The Generic Pharmaceuticals portfolio includes a variety of branded prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The Sterile Injectables segment consists primarily of branded sterile injectable products such as Vasostrict, Adrenalin and Aplisol, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The Branded Pharmaceuticals segment consists of the company's legacy generics business together with the generic pharmaceuticals products obtained through the September 2015 acquisition of Par Pharmaceutical Holdings, Inc. Endo International plc(NasdaqGS:ENDP) dropped from S&P Pharmaceuticals Select Industry Index. 4/2/18 - Endo agrees to extend the temporary stay of litigation against the FDA regarding the Drug. The four reportable business segments are: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. The total legal bill for Endos transgressions involving Lidoderm now total nearly 300 million. The company was founded in 1997 and is headquartered Dublin, Ireland. Stock quotes are provided by Factset, Morningstar and S&P Capital. Contact Us with any questions or search this site for more information.ĭo Not Sell or Share My Personal InformationEndo International plc is a global specialty pharmaceutical company, which is focused on branded and generic pharmaceuticals. Earnings Flash (ENDPQ) ENDO INTERNATIONAL Posts Q1 Revenue 515M. ![]() Initially, the driving force for the rise was a report by WJHL-TV in Johnson City. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Shares of Endo Pharmaceuticals ( ENDP) were on the rise Wednesday. Your use of the information on this site is subject to the terms of our Legal Notice. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. BMO Capital Adjusts Endo International Price Target to 4 From 8, Maintains Market Perform Rating. Citigroup Adjusts Endo Internationals Price Target to 6 From 11, Reiterates Buy Rating. This site is governed solely by applicable U.S. Piper Sandler Downgrades Endo International to Underweight From Neutral, Lowers PT to 1 From 3. There are a couple of factors that fueled this. If you are an individual with a disability please check our Disability Assistance page for information on how to request an accommodation. The stock price of Endo Pharmaceuticals (NASDAQ: ENDP) has seen a stellar 58 rise over the last month, while it is up 31 in a week. Equal Employment Opportunity Posters and GINA Supplement. Get The Latest ENDP Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ![]() All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability. AYRO (NASDAQ: AYRO) Endo International (NASDAQ: ENDP) Monaker Group (NASDAQ: MKGI) OMNIQ (OTCMKTS: OMQS) Sundial With all of this in mind, lets take. Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |